A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

NCT05607693 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Castration-Resistant Prostate Cancer

Interventions

DRUG: SHR3680 tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.